-
Non Regulatory October 26, 2020Oasmia Secures Important IP Rights
-
Non Regulatory October 20, 2020Oasmia to present at Bio Europe Digital on October 26-29
-
Regulatory October 14, 2020The Disciplinary Committee of Nasdaq Stockholm orders Oasmia to pay a fine
Oasmia Pharmaceutical published its Q1 report on September 9, 2020, at 08.00 am CEST.
Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®